ID
21490
Beskrivning
This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL); ODM derived from: https://clinicaltrials.gov/show/NCT00517218
Länk
https://clinicaltrials.gov/show/NCT00517218
Nyckelord
Versioner (1)
- 2017-04-24 2017-04-24 -
Uppladdad den
24 april 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Lymphocytic Leukemia NCT00517218
Eligibility Lymphocytic Leukemia NCT00517218
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beskrivning
Absolute lymphocyte count
Datatyp
boolean
Alias
- UMLS CUI [1]
- C3544087
Beskrivning
Chemotherapy Chronic Lymphocytic Leukemia | Therapeutic procedure Chronic Lymphocytic Leukemia | Transplantation, Homologous
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0392920
- UMLS CUI [1,2]
- C0023434
- UMLS CUI [2,1]
- C0087111
- UMLS CUI [2,2]
- C0023434
- UMLS CUI [3]
- C0040739
Beskrivning
major surgery
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0679637
Beskrivning
Operative Surgical Procedures Adverse effects Serious | Recovering failed
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0543467
- UMLS CUI [1,2]
- C0879626
- UMLS CUI [1,3]
- C0205404
- UMLS CUI [2,1]
- C0521108
- UMLS CUI [2,2]
- C0231175
Beskrivning
Autoimmune hemolytic anemia | Autoimmune thrombocytopenia
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0002880
- UMLS CUI [2]
- C0242584
Beskrivning
Communicable Disease Serious | Anti-infective therapy Systemic Patient need for
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0009450
- UMLS CUI [1,2]
- C0205404
- UMLS CUI [2,1]
- C1141958
- UMLS CUI [2,2]
- C0205373
- UMLS CUI [2,3]
- C0686904
Similar models
Eligibility Lymphocytic Leukemia NCT00517218
- StudyEvent: Eligibility
C0332155 (UMLS CUI [1,2])
C0023434 (UMLS CUI [2,1])
C0205103 (UMLS CUI [2,2])
C1514715 (UMLS CUI [2,3])
C0023434 (UMLS CUI [3,1])
C0332167 (UMLS CUI [3,2])
C1514715 (UMLS CUI [3,3])
C0023434 (UMLS CUI [2])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0023434 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0023434 (UMLS CUI [2,2])
C0040739 (UMLS CUI [3])
C0879626 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0521108 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C0242584 (UMLS CUI [2])
C0205404 (UMLS CUI [1,2])
C1141958 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0686904 (UMLS CUI [2,3])